Marie Bosslett, Assistant Editor

Happy Head's StrandIQ system revolutionizes hair loss treatment with personalized genetic analysis, enhancing hair growth and scalp health for individuals.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Sofia Wenzler, PhD, addresses misconceptions about dermatillomania (skin picking) and trichotillomania (hair pulling), advocating for compassionate care and accessible treatment for BFRBs.

Almirall and Absci enhance their collaboration, leveraging AI to revolutionize drug discovery for challenging dermatological conditions and improve patient outcomes.

Biofrontera Inc. advances acne treatment with aminolevulinic acid hydrochloride gel, completing a phase 2b study for moderate to severe cases.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of September.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

In case you missed it, this week we had news about the potential of an mRNA vaccine for acne, the clinical role of DecisionDx-SCC, the presence of global dermatology deserts, and more.

Explore the latest breakthroughs in treatment and research during Hair Loss Awareness Month, enhancing understanding and patient care for hair loss disorders.

Katrina Lee, MD, discussed innovative strategies and challenges in managing HS at the Dermatology Innovation Symposium, emphasizing early intervention and comprehensive care.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Research highlights that educational videos on standardized clinical photography protocols significantly lead to better management and treatment outcomes for patients with alopecia.

Discover the latest in regenerative aesthetics and body contouring at DERM 2025, featuring insights from Suneel Chilukuri, MD, on skin care trends and biohacking.

Lisa Swanson, MD, FAAD, shares innovative insights on pediatric dermatology, emphasizing effective treatments and communication strategies for young patients at DERM 2025.

Key regulatory milestones for MAL-838, a novel sCD83-based, hormone-free hair growth ingredient, are paving the way for the market launch of a microbiome-friendly 8T3 product line.

This review of the latest dermatologic studies focuses on chronic spontaneous urticaria with new research on the transition from omalizumab to dupilumab, metabolic syndrome in urticaria patients, current pediatric CSU guidelines, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Andrew Baker, MBA, MPAS, PA-C, discusses new data highlighting both the growing challenges—like burnout and reimbursement cuts—and exciting opportunities in leadership, virtual care, and mentorship for PAs and NPs.

Discover how biologic coordinators streamline dermatologic care through detailed protocols, clinical documentation, and patient advocacy to improve access to life-changing biologic therapies.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of August.

Joshua Zeichner, MD, spoke to Dermatology Times about Sanofi's clinical trials for the world’s first mRNA acne vaccine, aiming to revolutionize treatment by targeting the body’s inflammatory response rather than just symptoms.

In case you missed it, this week we had news about Art Garfunkel's decades-long journey with psoriasis, the first in-human trial of SEP-631 for CSU, the impact of World Skin Health Day, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

April Martinez-Dulay, MSN, APRN, FNP-BC, shares insights on diagnosing and treating types of dermatitis at DERM 2025, emphasizing innovative approaches and patient care strategies.

Vinna Crisostomo, MD, leads vital skin health initiatives in Palawan, addressing access and education challenges for underserved communities on World Skin Health Day.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

James Song, MD, FAAD, reveals insights on abrocitinib's safety in atopic dermatitis, highlighting lower conjunctivitis rates compared to dupilumab at DERM 2025.

In celebration of World Skin Health Day, Jasmin Jamora, MD, and her team at PDS enhance skin health access in remote areas through outreach clinics and education.

World Skin Health Day unites global dermatology leaders to enhance skin health awareness, access, and equity in underserved communities worldwide.

At DERM 2025, David Cotter, MD, PhD, shared how GEP testing revolutionizes skin cancer management and enhances patient care at the forefront of dermatology innovation.